Thursday May 25th 2017

Posts Tagged ‘Msrc’

Helen Yates of MSRC discusses MS & CCSVI

Helen Yates of MSRC discusses MS & CCSVI

Helen Yates, Chief Executive of MSRC discusses MS and Chronic Cerebrospinal Venous Insufficiency – CCSVI on BBC Radio Essex. Posted by Harris Luis [Read More]

Helen Live on BBC Essex talking about CCSVI

Helen Live on BBC Essex talking about CCSVI

petitions.number10.gov.uk please ask all family and friends to sign Helen from www.msrc.co.uk, the leading MS website in the UK ccsvi awareness group www.ms-ccsvi-uk.org Posted by Harris Luis [Read More]

Latest Topics

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of [Read More]

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

US-based biopharmaceutical firm Celgene has reported positive results from the Phase III RADIANCE clinical trial of [Read More]